Skip to main content


Nasal Biomarkers Identification and characterisation to reduce severity and transmissibility of COVID-19: findings from BIOMEVACn project*.

Dr. David Pinzauti

  • Crucial role of the respiratory tract microbiota in health and infection defense.
  • Impact of respiratory viruses on microbiota composition.
  • Research methods.
  • Presentation of key findings regarding nasal microbiota changes in infected patients.
  • Clinical Insights: potential clinical implications of altered nasal microbiota in SARS-CoV-2-infected individuals.

*Study financed through the Research and Development Scheme 2020 Project Ref. 16203 24102 granted by Malta Enterprise.

Date: Thursday 4th April 2024

Time: 14:00 GMT+1

    Missed a Webinar?

    Use the form above to sign-up & we will send you credentials to watch past webinars!